Looking forward to the FDA letter news.

Maybe rose-colored glasses, but Don seemed pretty enthusiastic about "break-through" status with tthe FDA. Trying not to read too much into that prior to the FDA letter though, but he seemd excited. He addtionally mentioned numerous times phrases like "in short order" and "soon" witth partnerships, and it seemed even commercial advancement. I will have to go back and listen again though ...

I know this is a challenge, so I don't want to get my hopes up, but there was some very interesting data. Here's hoping unmet need, costs in the industry, and some stellar and statistically significant data in some specific "large market" areas helps for a "Break-through' for everyone ...